Subgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal-IRI)±-5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based (gem) therapy.

被引：0
作者：
Macarulla, Teresa Mercade
Hubner, Richard
Blanc, Jean-Frederic
Wang-Gillam, Andrea
Li, Chung-Pin
Bodoky, Gyorgy
Dean, Andrew Peter
Yanshen, Shan
Jameson, Gayle S.
Lee, Kyung-Hun
Chiu, Chang-Fang
Schwartsmann, Gilberto
Braiteh, Fadi S.
Cunningham, David
Chen, Li-Tzong
Von Hoff, Daniel D.
Mamlouk, Khalid Kevin
de Jong, Floris A.
Siveke, Jens T.
机构：
[1] Vall d Hebron Univ Hosp, Inst Oncol, Barcelona, Spain
[2] Christie NHS Fdn Trust, Manchester, Lancs, England
[3] CHU Bordeaux, Pole ADEN, Hop Haut Leveque, Bordeaux, France
[4] Washington Univ, Sch Med St Louis, St Louis, MO USA
[5] Taipei Vet Gen Hosp, Taipei, Taiwan
[6] Szent Laszlo Teaching Hosp, Budapest, Hungary
[7] St John God Hosp, Subiaco, WA, Australia
[8] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[9] Honor Hlth, Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[10] Seoul Natl Univ Hosp, Seoul, South Korea
[11] China Med Univ First Hosp, Taichung, Taiwan
[12] Fed Univ, Porto Alegre, RS, Brazil
[13] Comprehens Canc Centers Nevada, Las Vegas, NV USA
[14] Royal Marsden NHS Fdn Trust, London, England
[15] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan
[16] Ipsen Biosci Inc, Cambridge, MA USA
[17] Shire GmbH, Zug, Switzerland
[18] Univ Hosp Essen, West German Canc Ctr, Essen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
410
引用
收藏
页数：1
相关论文
共 49 条
[31]   Quality-adjusted time without symptoms or toxicity (Q-TWIST) of nanoliposomal irinotecan (nal-IRI;MM-398) plus 5-fluorouracil and leucavorin (5-FU/LV) vs 5-FU/LV alone in patients with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy [J].
Pelzer, U. ;
Blanc, J. -F ;
Melisi, D. ;
Cubillo, A. ;
Von Hoff, D. D. ;
Wang-Gillam, A. ;
Chen, L. -T ;
Siveke, J. T. ;
Wan, Y. ;
Solem, C. T. ;
Botteman, M. ;
Yang, Y. ;
de Jong, F. ;
Hubner, R. .
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 :260-260
[32]   Final results from the NIFTY trial, a phase IIb, randomized, open-label study of liposomal Irinotecan (nal-IRI) plus fluorouracil (5-FU)/leucovorin (LV) in patients (pts) with previously treated metastatic biliary tract cancer (BTC) [J].
Yoo, C. ;
Kim, K-P. ;
Kim, I. ;
Kang, M. J. ;
Cheon, J. ;
Kang, B. W. ;
Ryu, H. ;
Jeong, J. ;
Lee, J. S. ;
Kim, K. W. ;
Ryoo, B-Y. ;
Abou-Alfa, G. K. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S565-S565
[33]   Final results from the NIFTY trial, a phase IIb, randomized, open-label study of liposomal irinotecan (nal-IRI) plus fluorouracil (5-FU)/leucovorin (LV) in patients (pts) with previously treated metastatic biliary tract cancer (BTC) [J].
Kim, I-H. .
ANNALS OF ONCOLOGY, 2022, 33 :S1464-S1464
[34]   Nomogram for Predicting Overall Survival in Patients Treated With Liposomal Irinotecan +/- 5-Fluorouracil/Leucovorin in Metastatic Pancreatic Ductal Adenocarcinoma Previously Treated With Gemcitabine-Based Therapy in NAPOLI-1 [J].
Bekaii-Saab, Tanios .
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) :14-14
[35]   A phase 1/2, open-label dose-escalation study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer (mPAC). [J].
Dean, Andrew Peter ;
Wainberg, Zev A. ;
Ramanathan, Ramesh K. ;
Boland, Patrick McKay ;
Mody, Kabir ;
Zhang, Bin ;
Belanger, Bruce ;
de Jong, Floris A. ;
Braun, Stephan .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[36]   Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis [J].
Uwe Pelzer ;
Jean-Frédéric Blanc ;
Davide Melisi ;
Antonio Cubillo ;
Daniel D Von Hoff ;
Andrea Wang-Gillam ;
Li-Tzong Chen ;
Jens T Siveke ;
Yin Wan ;
Caitlyn T Solem ;
Marc F Botteman ;
Yoojung Yang ;
Floris A de Jong ;
Richard A Hubner .
British Journal of Cancer, 2017, 116 :1247-1253
[37]   Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis [J].
Pelzer, Uwe ;
Blanc, Jean-Frederic ;
Melisi, Davide ;
Cubillo, Antonio ;
Von Hoff, Daniel D. ;
Wang-Gillam, Andrea ;
Chen, Li-Tzong ;
Siveke, Jens T. ;
Wan, Yin ;
Solem, Caitlyn T. ;
Botteman, Marc F. ;
Yang, Yoojung ;
de Jong, Floris A. ;
Hubner, Richard A. .
BRITISH JOURNAL OF CANCER, 2017, 116 (10) :1247-1253
[38]   Effects of nal-IRI (MM-398) ± 5-fluorouracil on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine [J].
Hubner, R. ;
Cubillo, A. ;
Blanc, J. -F. ;
Melisi, D. ;
Von Hoff, D. ;
Wang-Gillam, A. ;
Chen, L. -T. ;
Becker, C. ;
Mamlouk, K. ;
Belanger, B. ;
Yang, Y. ;
De Jong, F. ;
Siveke, J. .
ANNALS OF ONCOLOGY, 2016, 27 :119-119
[39]   Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/IN in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy. [J].
Chen, Li-Tzong ;
Siveke, Jens T. ;
Wang-Gillam, Andrea ;
Hubner, Richard ;
Pant, Shubham ;
Dragovich, Tomislav ;
Chung, Vincent M. ;
Chang, David Z. ;
Ross, Paul J. ;
Cooray, Prasad ;
Tebbutt, Niall C. ;
Franke, Fabio A. ;
Belanger, Bruce ;
Dhindsa, Navreet ;
de Jong, Floris ;
Mamlouk, Khalid ;
Von Hoff, Daniel D. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[40]   Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy [J].
Chen, Li-Tzong ;
Von Hoff, Daniel D. ;
Li, Chung-Pin ;
Wang-Gillam, Andrea ;
Bodoky, Gyorgy ;
Dean, Andrew Peter ;
Shan, Yan-Shen ;
Jameson, Gayle S. ;
Macarulla, Teresa ;
Lee, Kyung-Hun ;
Cunningham, David ;
Blanc, Jean-Frederic ;
Hubner, Richard ;
Chiu, Chang-Fang ;
Schwartsmann, Gilberto ;
Siveke, Jens T. ;
Braiteh, Fadi S. ;
Moyo, Victor M. ;
Belanger, Bruce ;
Bayever, Eliel .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345